FIGS Is Up 12% in a Month on a Raised Outlook. Its CEO Sees “Sustainable Top- and Bottom-Line Momentum” Ahead

Nikko Henson • 4 minute read
Reviewed by: David Hanson
Last updated Nov 19, 2026

Minerva Studio via Canva

Key Takeaways

  • FIGS stock is up 12% in the past month after third-quarter revenue grew 25.7% and the company raised its 2026 outlook.
  • The margin gain came from expenses growing slower than sales, with little help from tariff refunds.
  • Analysts expect 2027 EPS of just $0.43, barely above 2026’s $0.41.
  • FIGS now trades at a richer multiple than Cintas, so its first 2027 outlook, likely in late February, has to lift estimates.

FIGS (FIGS) stock is up 12% in the past month, while the Nasdaq 100 fell 7%. Most of that came after its Nov. 5 third-quarter report.

That leaves the scrubs maker priced richer than uniform giant Cintas (CTAS), which just raised its own outlook on a record operating margin.

Expenses did the heavy lifting

TIKR’s preview said FIGS needed a wider operating margin that didn’t lean on tariff refunds. It got one. Revenue rose 25.7% to $190.7 million against a guide of about 20%. Gross margin slipped 60 basis points to 69.3%, but operating expenses fell to 57.6% of revenue from 63.6%, and refunds added only about $1.9 million.

FIGS raised its 2026 outlook to about 23.5% revenue growth from about 20%. Its adjusted EBITDA margin outlook rose to about 15.8% from a 14.8% to 15.0% range. CEO Trina Spear said in the release: “We are also off to a great start in Q4 and believe we have a foundation for sustainable top- and bottom-line momentum as we look ahead to 2027.” Barclays raised its target to $28 from $24 and KeyBanc to $27 from $20 the next morning. On Nov. 9, Spear sold about $79.7 million of stock after exercising options due to expire in 2028.

TIKR tracks 10 analysts on FIGS. How many say “Buy”?

See the full breakdown of Buy, Hold, and Sell ratings on FIGS, along with Wall Street’s revenue and earnings estimates, all in one place. More than 500,000 investors use TIKR to research stocks like this one. See FIGS’s Analyst Ratings

Analysts see little growth in 2027

Analysts see normalized EPS more than doubling in 2026, then barely growing in 2027:

Bar chart from TIKR of FIGS's normalized EPS, actual and consensus estimates, $ per share, fiscal 2024-2029.
FIGS (FIGS): normalized EPS, actual and consensus estimates, $ per share, fiscal 2024-2029 (TIKR)

The 2026 estimate rose to $0.41 from $0.36 before the report, and 2027’s to $0.43 from $0.38. That’s about 5% growth, and 2026 includes tariff refunds that won’t repeat. And management expects stockouts tied to a blocked Jordanian supplier to last into the second quarter of 2027.

Even after an [8%] slide over the past week, FIGS trades at about 50x forward earnings:

Line chart from TIKR of FIGS's forward (NTM) P/E, last 5 years.
FIGS (FIGS): forward (NTM) P/E, last 5 years (TIKR)

That’s below its 77x five-year average, set when FIGS earned a fraction of today’s profit, but well above late September’s 40x. Cintas trades at 39x forward earnings and guides for adjusted EPS growth of 10.3% to 12.1% in its fiscal year ending May 2027. Its next report, in late December, will show us whether its record 23.6% operating margin holds.

Hold off until February

The quarter was excellent, and the stock still sits below the Street’s $23 average target. But at about 50x, investors are paying for 2027 growth analysts don’t model yet. I’d wait for management’s first 2027 outlook, likely in late February, and want double-digit revenue growth and a 2027 EPS estimate above $0.43 out of it. Of course, FIGS has topped its own revenue guide all year, so a cautious first look wouldn’t surprise me.

So what is FIGS stock actually worth?

TIKR lets you forecast the future price of any stock in less than a minute. Just enter a few assumptions into TIKR’s valuation model and see what FIGS could be worth. Start from Wall Street consensus estimates, or adjust the inputs to reflect your own view of the business. It’s free to use.

Value FIGS for free

Disclaimer:

Please note that the articles on TIKR are not intended to serve as investment or financial advice from TIKR or our content team, nor are they recommendations to buy or sell any stocks. We create our content based on TIKR Terminal’s investment data and analysts’ estimates. Our analysis might not include recent company news or important updates. TIKR has no position in any of the stocks mentioned. Thank you for reading, and happy investing!

Join thousands of investors worldwide who use TIKR to supercharge their investment analysis.

Sign Up for FREENo credit card required